Acute myeloid leukemia: 2014 Update on risk-stratification and management
Author:
Affiliation:
1. Division of Hematology; University of Washington and Member, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington
Publisher
Wiley
Subject
Hematology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/ajh.23834/fullpdf
Reference105 articles.
1. Assessment of differences in patient populations selected for excluded from participation in clinical phase III acute myelogenous leukemia trials;Mengis;J Clin Oncol,2003
2. Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry;Juliusson;Blood,2009
3. Intensive induction is effective in selected octogenarian acute myeloid leukemia patients: prognostic significance of karyotype and selected molecular markers used in the European LeukemiaNet classification;Wetzler;Haematologica,2014
4. Prediction of early death after induction therapy for newly diagnosed acute myeloid leukemia with pretreatment risk scores: a novel paradigm for treatment assignment;Walter;J Clin Oncol,2011
5. Age and acute myeloid leukemia;Appelbaum;Blood,2006
Cited by 115 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. High thrombospondin 1 expression is associated with aging and poor prognosis in patients with acute myeloid leukemia;2023-07-31
2. The prognostic value of RASGEF1A RNA expression and DNA methylation in cytogenetically normal acute myeloid leukemia;Cancer Biomarkers;2023-02-16
3. New drugs before, during, and after hematopoietic stem cell transplantation for patients with acute myeloid leukemia;Haematologica;2023-02-01
4. Factors influencing access to specialised haematology units during acute myeloblastic leukaemia patient care: A population‐based study in France;Cancer Medicine;2023-01-29
5. Pre-transplant gene profiling characterization by next-generation DNA sequencing might predict relapse occurrence after hematopoietic stem cell transplantation in patients affected by AML;Frontiers in Oncology;2022-12-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3